AffiAB® Anti-Fibrinogen Antibody [11-B3-D8]
The plasma glycoprotein Fibrinogen is synthesized in the liver and comprises three structurally different subunits: a, b and g. Fibrinogen is important in platelet aggregation, the final step of the coagulation cascade (i.e. the formation of Fibrin) and determination of plasma viscosity and erythrocyte aggregation. It is both constitutively expressed and inducible during an acute phase reaction. Hemostasis following tissue injury deploys essential plasma procoagulants (Prothrombin and Factors X, IX, V and VIII) , which are involved in a blood coagulation cascade leading to the formation of insoluble Fibrin clots and the promotion of platelet aggregation. Following vascular injury, Fibrinogen is cleaved by Thrombin to form Fibrin, which is the most abundant component of blood clots. The cleavage products of Fibrinogen regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types.
Antibody type
Mouse monoclonal Antibody
Uniprot ID
SwissProt: P02671 Human; SwissProt: P02675 Human; SwissProt: P02679 Human
Recombinant
NO
Conjugation
Non-conjugated
Host
Mouse
Isotype
IgG1
Clone
11-B3-D8
KO/KD
N/A
Species reactivity
Human
Tested applications
WB, IHC-P, ELISA
Predicted species reactivity
N/A
Immunogen
Native protein
Storage
Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Form
Liquid
Storage buffer
1*PBS (pH7.4) , 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration
2 mg/mL.
Purity
Protein A affinity purified.
Signal pathway
Cardiovascular
Recommended dilutions
WB: 1:500
; IHC-P: 1:50-1:200
; ELISA: 1:1, 000
Molecular Weight
Predicted band size: 95/56/52 kDa
Subcellular location
Secreted.
Positive control
N/A